Literature DB >> 808508

The effect of BCG on the course of experimental Chagas' disease in mice.

R E Kuhn, R T Vaughn, G A Herbst.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 808508     DOI: 10.1016/0020-7519(75)90049-1

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


× No keyword cloud information.
  6 in total

1.  [Suppression of parasitemia in rodent filariasis (Litomosoides carinii) by immunization with BCG and microfilaria. I. Intracutaneous inoculation of BCG].

Authors:  P Kimmig; P Wenk
Journal:  Z Parasitenkd       Date:  1982

2.  Susceptibility of pathogenic actinomycetes to antimicrobial compounds.

Authors:  P I Lerner
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

3.  Enhancement of delayed-type hypersensitivity to Trypanosoma cruzi in mice treated with Mycobacterium bovis BCG and cyclophosphamide.

Authors:  I A Abrahamsohn; M H Blotta; M A Curotto
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

4.  Interleukin 2 enhances specific and nonspecific immune responses in experimental Chagas' disease.

Authors:  L Choromanski; R E Kuhn
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

5.  Use of parasite antigens and interleukin-2 to enhance suppressed immune responses during Trypanosoma cruzi infection in mice.

Authors:  L Choromanski; R E Kuhn
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

6.  Effects of astaxanthin in mice acutely infected with Trypanosoma cruzi.

Authors:  José María Eloy Contreras-Ortiz; Alberto Barbabosa-Pliego; Rigoberto Oros-Pantoja; José Esteban Aparicio-Burgos; José Antonio Zepeda-Escobar; Wael Hegazy Hassan-Moustafa; Laucel Ochoa-García; María Uxúa Alonso-Fresan; Esvieta Tenorio Borroto; Juan Carlos Vázquez-Chagoyán
Journal:  Parasite       Date:  2017-05-31       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.